Blog
Featured post
Truveta Data includes linked closed claims for over 200 million patients
By linking complete clinical data with comprehensive claims records, Truveta advances real-world evidence (RWE) generation that can replace, or complement, clinical trials and registries.
Unlocking real-world data for cardiovascular research: The promise of complete and clean EHR data for drug and device development
The Centers for Disease Control and Prevention reports that cardiovascular (CV) disease is the leading cause of death for men, women, and people of most racial and ethnic groups...
Building a learning public health system
I can’t imagine our country without the FDA continuously assessing the safety and efficacy of medical products, or our government without the CDC monitoring and guiding public...
Alzheimer’s disease research: A new era
We are entering a new era of Alzheimer’s Disease research. Researchers from the University of Tsukuba in Japan along with IBM Research have recently developed a mobile app to...
Ozempic, Wegovy, and Mounjaro: On- and off-label prescribing trends
Beginning in Fall 2022, the news media has reported extensively on the use of Glucagon-like peptide-1 receptor agonist (GLP-1s) for weight loss (Belluz, 2023). Physicians have...
A pragmatic suggestion for medical AI regulation
There is a growing global consensus that “we need to regulate AI”. The most commonly cited suggestion is that we create a new global government agency to issue licenses for...
Unlocking insights: Stroke research with Truveta
Every 40 seconds, someone in the United States has a stroke. Every 3 minutes and 14 seconds, someone dies from a stroke. The fifth leading cause of death in the US and a leading...
Truveta spotlight: Dr. Marty Doerfler, EVP of Healthcare
Dr. Marty Doerfler has been an advocate for Truveta from its earliest days. He served as one of the original members of Truveta’s Board of Directors in his role at Northwell...
Q&A: Exploring with The Wall Street Journal Truveta’s EHR data on speech delays
The Wall Street Journal recently published a story, If Your Toddler Isn’t Talking Yet, the Pandemic Might Be to Blame, based on a new pre-print published by Truveta Research on...
Truveta expands its community to more than 40 healthcare and life science organizations
We are excited to announce the expansion of the Truveta community to include new life science partners, including Reprieve Cardiovascular and SK Life Science, joining previously...